Phase
Condition
Obesity
Diabetes Prevention
Weight Loss
Treatment
Mixed exercise
Muscle5 and TRIM7
Clinical Study ID
Ages 18-45 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
age 18 - 45 years
BMI > 25 kg/m2
low physical activity level < 150 min/week (< ACSM and CSEP recommendations)
have had two doses of the COVID-19 vaccine
Exclusion
Exclusion Criteria:
renal disease (creatinine > 140)
liver disease (i.e. diagnosed NAFLD, NASH, cirrhosis, previous liver transplant)
GI disorders (i.e. Colitis, Crohns)
cardiovascular disease (recent myocardial infarction (< 6 months), hypertensionrequiring more than 2 medications, congestive heart failure requiring more than onemedication for control, unstable arrhythmia, angina previous stroke with residualhemiparesis)
severe osteoarthritis
significant weight loss in the 3-month period prior to the study (10% of total bodyweight)
muscular dystrophy
severe peripheral neuropathy
severe osteoporosis
uncontrolled hypertension (>140/90 mmHg)
orthopedic problems
type I or II diabetes
respiratory conditions (i.e. chronic pulmonary obstructive disorder), chronicobstructive pulmonary disease (FVC or FEV1 < 70% of age predicted mean value), andasthma requiring more than two medications
individuals with prior bariatric surgery
women who have ammenorrhea, dysregulated menstrual cycle, are peri-menopausal,menopausal, pregnant, looking to become pregnant, or nursing
medications, including anti-inflammatory medications, more than one glucose loweringmedication, insulin, platelet inhibitors, anti-coagulant medications, or Simvastatin (zocor), beta-blockers, or weight loss medications (Orlistat, Saxenda Contrave) orany other medications known to affect protein metabolism (i.e.corticosteroids).
inability to take part in the exercise program
vegan
smoking
history of glaucoma or
overactive bladder syndrome
consumption of more than 10 drinks/week or 2 drinks/d for women and 15 drinks/weekor 3 drinks/d for men.
history of allergy, sensitivity or strong dislike towards any component of the studyproducts (supplements)
have undergone a barium swallow or an infusion of a contrast agent in the past 3weeks
have an implantable electronic device
inability to perform exercise as determined by the Get Active Questionnaire (GAQ)
inability to consent
participants on volitional dietary supplements will be considered on a case-by-casebasis, but they will be asked to refrain from intake for at least 2 weeks prior topartaking in this study.
Study Design
Study Description
Connect with a study center
Michaela Devries-Aboud
Waterloo, Ontario N2L3G1
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.